In its second respiratory-focused deal of the month, Clario is partnering with Strados Labs to use its FDA-approved monitoring device for clinical trials. Under the agreement, Philadelphia-based ...

In a multi-institutional study published today in Nature Nanotechnology, researchers from The University of Texas MD Anderson ...

Sanofi to pay $1.15 billion upfront for Vicebio, with up to $450 million in milestone payments. Vicebio’s VXB-241 RSV-hMPV combo vaccine is in Phase 1 trials in older adults. Get the data-driven ...

AI shows promise in diagnosing rare respiratory diseases but faces challenges like data privacy, bias, and hallucinations. Global equity in digital health access is crucial, with disparities ...

Annually, a staggering 20 million individuals globally find themselves connected to invasive respiratory support systems like ECMO and CBP. These systems, while crucial for survival, often necessitate ...

Opinions expressed by Digital Journal contributors are their own. As healthcare systems worldwide continue to address the effects of the COVID-19 pandemic, pharmaceutical companies like Amneal ...

Each winter, respiratory illness was once a predictable event: a rise in flu, a scattering of RSV cases, and a measurable but contained increase in hospital admissions. That rhythm no longer exists.

In today’s roundup, we talk about Huawei’s new Truesense wearable technology, Tecno’s new tri fold concept showcase, and Xiaomi’s potential changes in TV business strategy. How Huawei TruSense is ...